For uptake inhibition, D-UCMSCs were pretreated with increasing c

For uptake inhibition, D-UCMSCs were pretreated with increasing concentrations of D-galactose (0.03-100 μM; Sigma) for 1 hour at 37°C, then inoculated at an MOI of 103, in the presence of the inhibitor, for 4 hours at 37°C. DNA was extracted after extensive washing and trypsin treatment. We designed a TaqMan assay (RC01; Applied Biosystems ID:AIS07DM) able to specifically amplify a 106-bp region of the precore/core protein gene of genotype D HBV genome (which was common to all our viral sources). All samples were analyzed in triplicate by qPCR with a TaqMan standard 40-cycle amplification program with both annealing and elongation performed at 60°C. Beta-actin was used as the reference gene (Applied Biosystems).

The assay proved to have a very low limit of detection (4.5 IU with a Ct <38, hit rate 100% on 12 tests) and a wide dynamic range (up to 3.5 × 1010 IU, R2 = 0.999, PCR efficiency = 98.8%, P < 0.0001), while being highly reproducible Compound Library purchase and 100% specific for HBV DNA (Supporting Fig. 3). Full details on RC01 assay’s in silico analysis, validation with WHO 2nd HBV International Standard, and determination of sensibility and specificity are available in the Supporting Material. Ten μL of extracted DNA from each sample was digested with 30 IU of Plasmid-Safe DNase (PS-DNase, Epicentre Biotechnologies) Apoptosis inhibitor in a total volume of 50 μL, for 60 minutes at

37°C. PS-DNase selectively and efficaciously degrades linear DNA or circular single-stranded DNA without affecting cccDNA.24 We used RC01 assay to quantify cccDNA by qPCR. The results were normalized versus β-actin amplification in undigested samples. Detailed evaluation of PS-DNase digestion efficacy and RC01 specificity for cccDNA detection is available in the Supporting Material. RNA was extracted from D-UCMSCs at days 1, 3, and MCE公司 7 postinfection. After DNase I treatment and reverse transcription,

pregenomic (pg) and precore (preC) RNAs were measured by TaqMan qPCR using the RC01 assay as described above. A sample containing 1 ng plasmid pAM6 (corresponding to 34.6 × 109 IU HBV DNA/mL) was added to each experiment as internal control for efficient DNA digestion and results were excluded if amplification was detected in such a control. Experiments performed to assess specificity of reverse transcription (RT)-qPCR for viral RNAs are described in the Supporting Material. D-UCMSCs from three different donors (five experiments) were preincubated with 0.07-2.5 μg/mL tenofovir (phosphonylmethoxypropyladenine [PMPA], Rega Institute, Leuven, Belgium), for 1 hour. They were then inoculated at an MOI of 105 for 4 hours at 37°C, washed, and cultured in differentiation medium supplemented with PMPA over the full course of the experiment. DNA was extracted 7 days postinfection and intracellular HBV DNA was quantified by qPCR. Anti-HBV activity of PMPA was also tested on HepAD38 cells as described.19, 25 Viral RNA (pg and preC) was measured in 2.

Leave a Reply

Your email address will not be published. Required fields are marked *

*

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>